Home
Addiction
Active Chemicals in Cannabis Inhibits Prostate Cancer Cell Growth
According to researchers, active chemicals in cannabis inhibits prostate cancer cell growth.
Prostate cancer is the most common cancer in men in the UK, affecting more than 35,000 men in the UK each year. An estimated 192,280 new cases of prostate cancer will occur in the US during 2009. A quarter of all new cases of cancer diagnosed in men are prostate cancers.
The researchers tested the effects of the active chemicals in cannabis called cannabinoids on three human prostate cancer cell lines - called PC-3, DU-a45 and LNCaP.
The prostate cancer cells carry molecular ‘garages’, called receptors, in which cannabinoids can 'park'.
The scientists showed for the first time that if cannabinoids ‘park’ on a receptor called CB2, the cancer cells stop multiplying.
But Dr Lesley Walker, Cancer Research UK's director of cancer information warned patients against smoking the drug. She said: "It absolutely isn’t the case that men might be able to fight prostate cancer by smoking cannabis."
Dr Walker added: "This research suggest that prostate cancer cells might stop growing if they are treated with chemicals found in cannabis but more work needs to be done to explore the potential of the cannabinoids in treatment."
To confirm the findings the scientists switched off the CB2 receptors on the prostate cells. When cannabinoids were then added to cells without the CB2 receptor, the prostate cancer cells carried on dividing and growing. This suggests that cannabinoids connect with the CB2 receptors on prostate cancer cells to stop cell division and spread.
Professor Ines Diaz-Laviada, study author said: "Our research shows that there are areas on prostate cancer cells which can recognize and talk to chemicals found in cannabis called cannabinoids. These chemicals can stop the division and growth of prostate cancer cells and could become a target for new research into potential drugs to treat prostate cancer."
References:
1. N Olea-Herrero, D Vara, S Malagarie-Cazenave, I Díaz-Laviada. Inhibition of human tumour prostate PC-3 cell growth by cannabinoids R(+)-Methanandamide and JWH-015: Involvement of CB2. British Journal of Cancer, doi:10.1038/sj.bjc.6605248.
2. Cancer Research UK.
3. American cancer Society.
Related Articles
Both the reishi mushroom (Ganoderma lucidum; Lingzhi) and green tea have long held a place in traditional medicine in China and other Asian countries, for the general promotion of health and
|
It is generally recognized that cigarette smoking is the most important risk factor for bladder cancer. A recent study was undertaken to examine the relationships between smoking history of
|
Researchers have discovered variation around two genes that are associated with an increased risk of testicular cancer. This discovery is the first step toward understanding which men are at
|
Many people were hoping the long-awaited results of two major cancer prevention studies would deliver important news about stopping the spread of prostate cancer. But to the health
|
According to a report in the Archives of Internal Medicine, women with higher intake of calcium appear to have a lower risk of cancer overall, and both men and women with high calcium intakes
|
Latest Health News
 Tuesday, 09 February 2010
A Mediterranean diet may help people avoid the small areas of brain damage that can lead to problems with thinking
|
 Tuesday, 09 February 2010 {loadposition cardio_ads}
High blood pressure appears to predict the progression to dementia in older adults with impaired
|
 Monday, 08 February 2010
Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at
|
 Monday, 08 February 2010
Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold
|
 Monday, 08 February 2010
The benefits of marijuana in tempering or reversing the effects of Alzheimer's disease have been challenged in a new
|
 |
 |
 |
 |
 |
 |
 |